Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Atlassian
TEAM
|
+$437M |
| 2 |
AbbVie
ABBV
|
+$380M |
| 3 |
Workday
WDAY
|
+$366M |
| 4 |
Synopsys
SNPS
|
+$323M |
| 5 |
Advanced Micro Devices
AMD
|
+$286M |
Top Sells
| 1 |
Adobe
ADBE
|
+$1.71B |
| 2 |
Apple
AAPL
|
+$984M |
| 3 |
Boston Scientific
BSX
|
+$642M |
| 4 |
Microsoft
MSFT
|
+$599M |
| 5 |
Texas Instruments
TXN
|
+$491M |
Sector Composition
| 1 | Technology | 31.62% |
| 2 | Healthcare | 18.99% |
| 3 | Consumer Discretionary | 10.82% |
| 4 | Financials | 10.24% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
PotlatchDeltic
PCH
$3.22B
| $77.2M | 0.04% |
1,463,875
+108,580
| +8% | +$5.73M |
|
377
LivePerson
LPSN
$95.7M
| $77.1M | 0.04% |
3,157,994
-103,818
| -3% | -$2.54M |
|
378
Newmont
NEM
$83.4B
| $76.9M | 0.04% |
967,739
-99,347
| -9% | -$7.89M |
|
379
Arista Networks
ANET
$178B
| $76.7M | 0.04% |
2,208,444
+1,579,564
| +251% | +$54.9M |
|
380
Everest Group
EG
$14.3B
| $76.5M | 0.04% |
253,712
-36,701
| -13% | -$11.1M |
|
381
Toronto Dominion Bank
TD
$129B
| $75.7M | 0.04% |
952,914
+236,014
| +33% | +$18.7M |
|
382
Coterra Energy
CTRA
$18.2B
| $75.7M | 0.04% |
2,806,202
+374,411
| +15% | +$10.1M |
|
383
Williams Companies
WMB
$70.3B
| $75.7M | 0.04% |
2,264,841
-47,054
| -2% | -$1.57M |
|
384
Biogen
BIIB
$21.1B
| $75.6M | 0.04% |
358,995
+57,550
| +19% | +$12.1M |
|
385
SBA Communications
SBAC
$20.6B
| $75.3M | 0.04% |
218,605
+52,757
| +32% | +$18.2M |
|
386
Bunge Global
BG
$16.8B
| $75.2M | 0.04% |
678,735
-197,593
| -23% | -$21.9M |
|
|
MODV
387
DELISTED
ModivCare
MODV
| $75.2M | 0.04% |
651,792
-8,308
| -1% | -$959K |
|
388
Olaplex Holdings
OLPX
$967M
| $75.1M | 0.04% |
4,806,689
-139,944
| -3% | -$2.19M |
|
389
STAG Industrial
STAG
$6.75B
| $74.8M | 0.04% |
1,809,603
-427,024
| -19% | -$17.7M |
|
390
Azenta
AZTA
$1.35B
| $74.7M | 0.04% |
901,671
-282,798
| -24% | -$23.4M |
|
391
PepsiCo
PEP
$196B
| $74.7M | 0.04% |
446,215
-24,204
| -5% | -$4.05M |
|
392
iRhythm Technologies
IRTC
$5.99B
| $74.6M | 0.04% |
473,475
-20,161
| -4% | -$3.17M |
|
|
BCYC
393
Bicycle Therapeutics
BCYC
$493M
| $74.3M | 0.04% |
1,692,774
-2,635
| -0.2% | -$116K |
|
|
MYOV
394
DELISTED
Myovant Sciences Ltd.
MYOV
| $74.2M | 0.04% |
5,572,904
+45,440
| +0.8% | +$605K |
|
395
RenaissanceRe
RNR
$11.2B
| $74.2M | 0.04% |
467,915
+20,883
| +5% | +$3.31M |
|
|
RDFN
396
DELISTED
Redfin
RDFN
| $74M | 0.04% |
4,104,691
-2,358,613
| -36% | -$42.5M |
|
397
Lumen
LUMN
$5.78B
| $73.9M | 0.04% |
6,560,363
-551,081
| -8% | -$6.21M |
|
398
Chubb
CB
$110B
| $73.6M | 0.04% |
344,078
-31,470
| -8% | -$6.73M |
|
399
Innospec
IOSP
$2.07B
| $73.5M | 0.04% |
794,339
-114,721
| -13% | -$10.6M |
|
|
EGRX
400
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $73.5M | 0.04% |
1,485,404
-42,748
| -3% | -$2.12M |
|